A patient-centric, 2-step autoinjector

Built on a Modular Platform Technology

Available in 1.0 mL and 2.25 mL variations

Sleek and ergonomic design

  • Uncap and inject
  • Audible click at beginning and end of injection
  • Push-on-skin activation
  • Subcutaneous injections
  • Automatic needle cover lockout

Designed to be compatible with a variety of ISO standard syringes

Standard design with customizable colors

Flexible designs for unique brand and patient requirements

Scalable solutions for production, assembly, and final product testing

Streamlined processes and integrated services supported by full range of internal functions to enable faster development

A patient-centric, 2-step autoinjector

Built on a Modular Platform Technology

Available in 1.0 mL and 2.25 mL variations

Sleek and ergonomic design

Designed to be compatible with a variety of ISO standard syringes

Uncap and inject
Push-on-skin activation
Subcutaneous injections
Audible click at beginning
and end of injection
Automatic needle cover lockout

THE CUSTOMIZABLE PLATFORM

Standard design

with

customizable colors

Flexible designs

for unique brand and patient requirements

Scalable solutions for production, assembly, and final product testing

FROM PROJECT TO PRODUCT

Streamlined processes and integrated services

Supported by full range of internal functions

Enabling faster development

MODULAR PLATFORM TECHNOLOGY

ACHIEVEMENTS IN NUMBERS

SHL introduced Molly in 2010 as a 2-step autoinjector platform. In 2016, the first Molly combination product received marketing approval for autoimmune and inflammatory conditions. Molly has since seen a steady stream of approvals each year, with the most recent Molly launched in 2021 for a treatment addressing weight management.

Unparalleled track record of launches

SHL works with 12+ pharmaceutical companies to commercialize their Molly and Molly 2.25 autoinjectors. 17 combination products have been approved so far, including the world’s first high volume autoinjector with a ≥ 2.0 mL fill.
Systemic lupus erythematosus
Hypoglycemia
Weight management
Migraine
Autoimmune / Inflammatory
Autoimmune / Inflammatory

Unparalleled track record of launches

SHL works with 12+ pharmaceutical companies to commercialize their Molly and Molly 2.25 autoinjectors. 17 combination products have been approved so far, including the world’s first high volume autoinjector with a ≥ 2.0 mL fill.

Beyond the platform

Molly products that have successfully launched commercially include 7 that use SHL’s market-proven platform design and 10 that have been introduced with various levels of design customization. This also includes 4 designs built to be our pharmaceutical partner’s platform device.

Enabling patients’ independence around the world

Molly supports 14 molecular entities covering at least 25 clinical indications across various therapeutic areas. Molly has helped patients in at least 33 countries receive their self-injectable treatments in the comfort of their own homes.

CONNECTED THERAPEUTICS
INNOVATION PARTNERSHIP

Digital healthcare offers a new pathway for pharmaceutical companies to transform the injection experiences for patients, clinicians, and other stakeholders. SHL is connecting therapeutics by combining drug delivery technologies such as the Molly autoinjector with life-centric design in the form of the Connected Therapeutics (CTx) Innovation Partnership. The CTx Innovation Partnership is a co-creation process that leverages SHL’s technological capabilities with pharma’s clinical innovations. Together, we create the baseline for a tailored, innovative digital health ecosystem built on connectivity and meaningful data at scale.

TOWARD AN INHERENTLY
SUSTAINABLE AUTOINJECTOR

Our sustainability efforts are guided by our Environmental Social Governance Strategy 2030. We are implementing innovative initiatives across our portfolio and our sites with the goal of making all our products inherently sustainable by 2030.

Sustainable designs

We are committed to developing products that use sustainable design principles covering the entire product lifecycle from design to development to production. As part of this commitment, we will introduce alternative materials into our product designs and processes.

Leaner processes

We are constantly improving the manufacturing and material handling processes across our facilities. Our Liufu site in Taiwan, for example, already includes energy-efficient features and streamlined material handling processes that help reduce water usage, production waste, and CO2 emissions.

Cleaner production

Our new Zug production and office building in Switzerland is being built with an integrated solar power system and energy-efficient features. Connected with the Tech Cluster Zug’s Multi Energy Hub, the building will support sustainable production processes. Globally, we will begin transitioning all sites and offices to renewable energy (RE100) by 2025.

Powerful machinery

SHL has invested heavily in high-cavity, hot runner molds using fully electric molding machines. This has resulted in significant energy savings as well as cleaner and more efficient production.

Modular equipment

SHL’s modular component and equipment strategy means different variations of Molly devices can be assembled and tested using universal equipment with interchangeable fixtures. By reusing much of the same machinery for different projects, emissions from producing and operating individual machinery can be significantly reduced.

Sustainable packaging

At present, all trays used for internal/local transportation are reusable. We also plan to introduce trays made from 100% recycled plastics for all products before 2025. We have also launched an initiative to enable our customers to recycle sub-assembly trays within their facilities, facilitating closed-loop recycling.

Optimized supply chain

We have replaced single-use pallets and totes with reusable options. In the future, these will be made from recycled materials that are also recyclable. We are set to deploy additional measures in 2022, including updating our palletization schemes and harmonizing our shipping and intermediate storage configurations to continuously reduce our environmental footprint.

Trusted organizations

Sustainability is a global challenge that cannot be tackled alone. We are joining leading organizations and initiatives to elevate our own sustainability while also putting our weight behind the push for change.

Share this website

Any questions?

Please do not hesitate to ask for more information.
Contact us